1 STATE OF OKLAHOMA
1
2 1st Session of the 59th Legislature (2023)
2
3 SENATE BILL 549 By: Montgomery
3
4
4
5
5
6 AS INTRODUCED
6
7 An Act relating to pharmacy benefits management;
7 amending 36 O.S. 2021, Sections 319, 6960, as amended
8 by Section 1, Chapter 38, O.S.L. 2022, 6962, as
8 amended by Section 2, Chapter 38, O.S.L. 2022, 6965,
9 6966, and 6967 (36 O.S. Supp. 2022, Sections 6960 and
9 6962), which relate to hearings by the Patient’s
10 Right to Pharmacy Choice Commission and the Patient’s
10 Right to Pharmacy Choice Act; updating statutory
11 reference; conforming language; modifying
11 definitions; requiring certain insurer and pharmacy
12 benefits manager to submit certain audit;
12 establishing submission means for certain audit and
13 fee; providing time period to constitute certain
13 violation; prohibiting pharmacy benefits manager
14 contracts from certain amendment, revision, or
14 cancellation without certain notice and agreement;
15 establishing minimum for certain fines; amending 59
15 O.S. 2021, Sections 356.1, 357, and 360, which relate
16 to definitions and maximum allowable cost list;
16 modifying definitions; requiring pharmacy benefits
17 manager to adjust maximum allowable cost under
17 certain circumstances; updating statutory reference;
18 and providing an effective date.
18
19
19
20
20
21 BE IT ENACTED BY THE PEOPLE OF THE STATE OF OKLAHOMA:
21
22 SECTION 1. AMENDATORY 36 O.S. 2021, Section 319, is
22
23 amended to read as follows:
23
24
24
Req. No. 402 Page 1
1 Section 319. A. In conducting any hearing pursuant to the
1
2 Insurance Code, the Insurance Commissioner may appoint an
2
3 independent hearing examiner who shall sit as a quasi-judicial
3
4 officer. The ordinary fees and costs of such hearing examiner shall
4
5 be assessed by the hearing examiner against the respondent, unless
5
6 the respondent is the prevailing party. Within thirty (30) days
6
7 after termination of the hearing or of any rehearing thereof or
7
8 reargument thereon, unless such time is extended by stipulation, a
8
9 final order shall be issued.
9
10 B. 1. The Patient’s Right to Pharmacy Choice Commission
10
11 established pursuant to Section 10 of this act shall conduct any
11
12 hearing pursuant to the Patient’s Right to Pharmacy Choice Act or
12
13 relating to the oversight of pharmacy benefits managers pursuant to
13
14 the Pharmacy Audit Integrity Act and Sections 357 through 360 of
14
15 Title 59 of the Oklahoma Statutes hearings in accordance with
15
16 Section 6966 of this title. Within thirty (30) days after
16
17 termination of a hearing or of any rehearing thereof or reargument
17
18 thereon, unless such time is extended by stipulation, a final order
18
19 shall be issued.
19
20 2. The Pharmacy Choice Commission members shall not be entitled
20
21 to receive any compensation related to conducting a hearing pursuant
21
22 to this section including per diem or mileage for any travel or
22
23 expenses related to appointment on the Commission.
23
24
24
Req. No. 402 Page 2
1 SECTION 2. AMENDATORY 36 O.S. 2021, Section 6960, as
1
2 amended by Section 1, Chapter 38, O.S.L. 2022 (36 O.S. Supp. 2022,
2
3 Section 6960), is amended to read as follows:
3
4 Section 6960. For purposes of the Patient’s Right to Pharmacy
4
5 Choice Act:
5
6 1. “Health insurer” means any corporation, association, benefit
6
7 society, exchange, partnership or individual licensed by the
7
8 Oklahoma Insurance Code;
8
9 2. “Health insurer payor” means a health insurance company,
9
10 health maintenance organization, union, hospital and medical
10
11 services organization or any entity providing or administering a
11
12 self-funded health benefit plan;
12
13 3. “Mail-order pharmacy” means a pharmacy licensed by this
13
14 state that primarily dispenses and delivers covered drugs via common
14
15 carrier;
15
16 4. “Pharmacy benefits manager” or “PBM” means a person,
16
17 business, or entity that performs pharmacy benefits management, as
17
18 defined pursuant to Section 357 of Title 59 of the Oklahoma
18
19 Statutes, and any other person, business, or entity acting for such
19
20 person the PBM under a contractual or employment relationship in the
20
21 performance of pharmacy benefits management for a managed-care
21
22 company, nonprofit hospital, medical service organization, insurance
22
23 company, third-party payor or a health program administered by a
23
24
24
Req. No. 402 Page 3
1 department of this state provider or covered entity, as defined by
1
2 Section 357 of Title 59 of the Oklahoma Statutes;
2
3 5. “Provider” means a pharmacy, as defined in Section 353.1 357
3
4 of Title 59 of the Oklahoma Statutes or an agent or representative
4
5 of a pharmacy;
5
6 6. “Retail pharmacy network” means retail pharmacy providers
6
7 contracted with a PBM in which the pharmacy primarily fills and
7
8 sells prescriptions via a retail, storefront location;
8
9 7. “Rural service area” means a five-digit ZIP code in which
9
10 the population density is less than one thousand (1,000) individuals
10
11 per square mile;
11
12 8. “Spread pricing” means a prescription drug pricing model
12
13 utilized by a pharmacy benefits manager in which the PBM charges a
13
14 health benefit plan a contracted price for prescription drugs that
14
15 differs from the amount the PBM directly or indirectly pays the
15
16 pharmacy or pharmacist for providing pharmacy services;
16
17 9. “Suburban service area” means a five-digit ZIP code in which
17
18 the population density is between one thousand (1,000) and three
18
19 thousand (3,000) individuals per square mile; and
19
20 10. “Urban service area” means a five-digit ZIP code in which
20
21 the population density is greater than three thousand (3,000)
21
22 individuals per square mile.
22
23
23
24
24
Req. No. 402 Page 4
1 SECTION 3. AMENDATORY 36 O.S. 2021, Section 6962, as
1
2 amended by Section 2, Chapter 38, O.S.L. 2022 (36 O.S. Supp. 2022,
2
3 Section 6962), is amended to read as follows:
3
4 Section 6962. A. The Oklahoma Insurance Department shall
4
5 review and approve retail pharmacy network access for all pharmacy
5
6 benefits managers (PBMs) to ensure compliance with Section 6961 of
6
7 this title.
7
8 1. On a semi-annual basis, each health insurer payor that
8
9 utilizes the services of a PBM that is licensed in this state and
9
10 each PBM licensed in this state shall electronically submit a
10
11 network adequacy audit and any fees assessed to the Department in
11
12 the manner and form prescribed by the Insurance Commissioner.
12
13 2. Each calendar day in a single 5-digit postal code where a
13
14 PBM or insurer has failed to comply with the provisions of Section
14
15 6961 et seq. of this title shall be deemed an instance of violation.
15
16 B. A PBM, or an agent of a PBM, shall not:
16
17 1. Cause or knowingly permit the use of advertisement,
17
18 promotion, solicitation, representation, proposal or offer that is
18
19 untrue, deceptive or misleading;
19
20 2. Charge a pharmacist or pharmacy a fee related to the
20
21 adjudication of a claim including without limitation a fee for:
21
22 a. the submission of a claim,
22
23 b. enrollment or participation in a retail pharmacy
23
24 network, or
24
Req. No. 402 Page 5
1 c. the development or management of claims processing
1
2 services or claims payment services related to
2
3 participation in a retail pharmacy network;
3
4 3. Reimburse a pharmacy or pharmacist in the state an amount
4
5 less than the amount that the PBM reimburses a pharmacy owned by or
5
6 under common ownership with a PBM for providing the same covered
6
7 services. The reimbursement amount paid to the pharmacy shall be
7
8 equal to the reimbursement amount calculated on a per-unit basis
8
9 using the same generic product identifier or generic code number
9
10 paid to the PBM-owned or PBM-affiliated pharmacy;
10
11 4. Deny a provider the opportunity to participate in any
11
12 pharmacy network at preferred participation status if the provider
12
13 is willing to accept the terms and conditions that the PBM has
13
14 established for other providers as a condition of preferred network
14
15 participation status;
15
16 5. Deny, limit or terminate a provider’s contract based on
16
17 employment status of any employee who has an active license to
17
18 dispense, despite probation status, with the State Board of
18
19 Pharmacy;
19
20 6. Retroactively deny or reduce reimbursement for a covered
20
21 service claim after returning a paid claim response as part of the
21
22 adjudication of the claim, unless:
22
23 a. the original claim was submitted fraudulently, or
23
24
24
Req. No. 402 Page 6
1 b. to correct errors identified in an audit, so long as
1
2 the audit was conducted in compliance with Sections
2
3 356.2 and 356.3 of Title 59 of the Oklahoma Statutes;
3
4 7. Fail to make any payment due to a pharmacy or pharmacist for
4
5 covered services properly rendered in the event a PBM terminates a
5
6 provider from a pharmacy benefits manager network;
6
7 8. Conduct or practice spread pricing, as defined in Section 1
7
8 of this act, in this state; or
8
9 9. Charge a pharmacist or pharmacy a fee related to
9
10 participation in a retail pharmacy network including but not limited
10
11 to the following:
11
12 a. an application fee,
12
13 b. an enrollment or participation fee,
13
14 c. a credentialing or re-credentialing fee,
14
15 d. a change of ownership fee, or
15
16 e. a fee for the development or management of claims
16
17 processing services or claims payment services.
17
18 C. The prohibitions under this section shall apply to contracts
18
19 between pharmacy benefits managers and providers for participation
19
20 in retail pharmacy networks.
20
21 1. A PBM contract shall:
21
22 a. not restrict, directly or indirectly, any pharmacy
22
23 that dispenses a prescription drug from informing, or
23
24 penalize such pharmacy for informing, an individual of
24
Req. No. 402 Page 7
1 any differential between the individual’s out-of-
1
2 pocket cost or coverage with respect to acquisition of
2
3 the drug and the amount an individual would pay to
3
4 purchase the drug directly, and
4
5 b. ensure that any entity that provides pharmacy benefits
5
6 management services under a contract with any such
6
7 health plan or health insurance coverage does not,
7
8 with respect to such plan or coverage, restrict,
8
9 directly or indirectly, a pharmacy that dispenses a
9
10 prescription drug from informing, or penalize such
10
11 pharmacy for informing, a covered individual of any
11
12 differential between the individual’s out-of-pocket
12
13 cost under the plan or coverage with respect to
13
14 acquisition of the drug and the amount an individual
14
15 would pay for acquisition of the drug without using
15
16 any health plan or health insurance coverage,
16
17 c. not be amended or modified unilaterally by any party
17
18 to the original or subsequent contract without
18
19 providing proper notice, in the form and manner
19
20 prescribed by the Department, to all other parties to
20
21 the contract and agreement to the changes by all
21
22 parties to the contract. Agreement shall be evidenced
22
23 by the signature of a party to the contract affixed to
23
24 the amendment or modification, and
24
Req. No. 402 Page 8
1 d. not be unilaterally cancelled by any party to a
1
2 contract on or before the date of renewal without
2
3 providing proper notice in the form and manner
3
4 prescribed by the Department to all other parties to
4
5 the contract.
5
6 2. A pharmacy benefits manager’s contract with a provider shall
6
7 not prohibit, restrict or limit disclosure of information to the
7
8 Insurance Commissioner, law enforcement or state and federal
8
9 governmental officials investigating or examining a complaint or
9
10 conducting a review of a pharmacy benefits manager’s compliance with
10
11 the requirements under the Patient’s Right to Pharmacy Choice Act.
11
12 D. A pharmacy benefits manager shall:
12
13 1. Establish and maintain an electronic claim inquiry
13
14 processing system using the National Council for Prescription Drug
14
15 Programs’ current standards to communicate information to pharmacies
15
16 submitting claim inquiries;
16
17 2. Fully disclose to insurers, self-funded employers, unions or
17
18 other PBM clients the existence of the respective aggregate
18
19 prescription drug discounts, rebates received from drug
19
20 manufacturers and pharmacy audit recoupments;
20
21 3. Provide the Insurance Commissioner, insurers, self-funded
21
22 employer plans and unions unrestricted audit rights of and access to
22
23 the respective PBM pharmaceutical manufacturer and provider
23
24
24
Req. No. 402 Page 9
1 contracts, plan utilization data, plan pricing data, pharmacy
1
2 utilization data and pharmacy pricing data;
2
3 4. Maintain, for no less than three (3) years, documentation of
3
4 all network development activities including but not limited to
4
5 contract negotiations and any denials to providers to join networks.
5
6 This documentation shall be made available to the Commissioner upon
6
7 request; and
7
8 5. Report to the Commissioner, on a quarterly basis for each
8
9 health insurer payor, in the manner and form prescribed by the
9
10 Commissioner, accompanied by payment of any fees assessed, on the
10
11 following information:
11
12 a. the aggregate amount of rebates received by the PBM,
12
13 b. the aggregate amount of rebates distributed to the
13
14 appropriate health insurer payor,
14
15 c. the aggregate amount of rebates passed on to the
15
16 enrollees of each health insurer payor at the point of
16
17 sale that reduced the applicable deductible,
17
18 copayment, coinsure or other cost sharing amount of
18
19 the enrollee,
19
20 d. the individual and aggregate amount paid by the health
20
21 insurer payor to the PBM for pharmacy services
21
22 itemized by pharmacy, drug product and service
22
23 provided, and
23
24
24
Req. No. 402 Page 10
1 e. the individual and aggregate amount a PBM paid a
1
2 provider for pharmacy services itemized by pharmacy,
2
3 drug product and service provided.
3
4 SECTION 4. AMENDATORY 36 O.S. 2021, Section 6965, is
4
5 amended to read as follows:
5
6 Section 6965. A. The Insurance Commissio